QuidelOrtho Statistics
Total Valuation
QuidelOrtho has a market cap or net worth of $1.02 billion. The enterprise value is $3.97 billion.
| Market Cap | 1.02B |
| Enterprise Value | 3.97B |
Important Dates
The last earnings date was Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
QuidelOrtho has 68.58 million shares outstanding. The number of shares has increased by 0.89% in one year.
| Current Share Class | 68.58M |
| Shares Outstanding | 68.58M |
| Shares Change (YoY) | +0.89% |
| Shares Change (QoQ) | +0.15% |
| Owned by Insiders (%) | 1.12% |
| Owned by Institutions (%) | 111.85% |
| Float | 61.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 19.13 |
| PS Ratio | 0.38 |
| Forward PS | 0.40 |
| PB Ratio | 0.57 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.49 |
| EV / EBITDA | 8.20 |
| EV / EBIT | 107.13 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.39, with a Debt / Equity ratio of 1.73.
| Current Ratio | 1.39 |
| Quick Ratio | 0.60 |
| Debt / Equity | 1.73 |
| Debt / EBITDA | 5.82 |
| Debt / FCF | n/a |
| Interest Coverage | 0.18 |
Financial Efficiency
Return on equity (ROE) is -45.91% and return on invested capital (ROIC) is 0.80%.
| Return on Equity (ROE) | -45.91% |
| Return on Assets (ROA) | 0.38% |
| Return on Invested Capital (ROIC) | 0.80% |
| Return on Capital Employed (ROCE) | 0.79% |
| Weighted Average Cost of Capital (WACC) | 5.95% |
| Revenue Per Employee | $411,415 |
| Profits Per Employee | -$161,292 |
| Employee Count | 6,500 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 2.46 |
Taxes
In the past 12 months, QuidelOrtho has paid $18.40 million in taxes.
| Income Tax | 18.40M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.08% in the last 52 weeks. The beta is 0.69, so QuidelOrtho's price volatility has been lower than the market average.
| Beta (5Y) | 0.69 |
| 52-Week Price Change | -46.08% |
| 50-Day Moving Average | 15.78 |
| 200-Day Moving Average | 19.69 |
| Relative Strength Index (RSI) | 48.23 |
| Average Volume (20 Days) | 1,692,732 |
Short Selling Information
The latest short interest is 13.01 million, so 18.96% of the outstanding shares have been sold short.
| Short Interest | 13.01M |
| Short Previous Month | 11.80M |
| Short % of Shares Out | 18.96% |
| Short % of Float | 21.26% |
| Short Ratio (days to cover) | 11.30 |
Income Statement
In the last 12 months, QuidelOrtho had revenue of $2.67 billion and -$1.05 billion in losses. Loss per share was -$15.40.
| Revenue | 2.67B |
| Gross Profit | 1.20B |
| Operating Income | 37.10M |
| Pretax Income | -1.03B |
| Net Income | -1.05B |
| EBITDA | 484.60M |
| EBIT | 37.10M |
| Loss Per Share | -$15.40 |
Balance Sheet
The company has $123.40 million in cash and $3.08 billion in debt, with a net cash position of -$2.95 billion or -$43.05 per share.
| Cash & Cash Equivalents | 123.40M |
| Total Debt | 3.08B |
| Net Cash | -2.95B |
| Net Cash Per Share | -$43.05 |
| Equity (Book Value) | 1.77B |
| Book Value Per Share | 25.99 |
| Working Capital | 383.20M |
Cash Flow
In the last 12 months, operating cash flow was -$57.20 million and capital expenditures -$154.00 million, giving a free cash flow of -$211.20 million.
| Operating Cash Flow | -57.20M |
| Capital Expenditures | -154.00M |
| Depreciation & Amortization | 447.50M |
| Net Borrowing | 271.20M |
| Free Cash Flow | -211.20M |
| FCF Per Share | -$3.08 |
Margins
Gross margin is 44.86%, with operating and profit margins of 1.39% and -39.20%.
| Gross Margin | 44.86% |
| Operating Margin | 1.39% |
| Pretax Margin | -38.52% |
| Profit Margin | -39.20% |
| EBITDA Margin | 18.12% |
| EBIT Margin | 1.39% |
| FCF Margin | n/a |
Dividends & Yields
QuidelOrtho does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.89% |
| Shareholder Yield | -0.89% |
| Earnings Yield | -102.54% |
| FCF Yield | -20.66% |
Analyst Forecast
The average price target for QuidelOrtho is $14.67, which is -1.61% lower than the current price. The consensus rating is "Hold".
| Price Target | $14.67 |
| Price Target Difference | -1.61% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | -0.56% |
| EPS Growth Forecast (3Y) | -5.15% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
QuidelOrtho has an Altman Z-Score of 0.52 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.52 |
| Piotroski F-Score | 4 |